| Announce Date | 10/15/2025 |
| EPS Normalized Actual | $2.8 (Beat by $0.7) |
| EPS GAAP Actual | $2.8 (Beat by $0.7) |
| Revenue Actual | $31.189B |
| Revenue Surprise | Beat by $31189M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 13.6879 | 11.98 | 13.01 | 14.12076 | 11 |
| Dec 2028 | 10.67839 | 15.36 | 10.09883 | 11.41254 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.83 | 2.83 | 31.189B | 50.93% | 31189M |
| FQ2 2025 (Jun 2025) | 2.13 | 2.13 | 29.35B | 48.83% | 29350M |
| FQ1 2025 (Mar 2025) | 2.62 | 2.62 | 29.134B | 9.83% | 29134M |
| FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 16.108B | 25.31% | 16108M |
| FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 15.304B | 18.86% | 15304M |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 15.019B | 16.23% | 15019M |
| FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 26.27B | 48.09% | 26270M |
| FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 12.031B | 1.11% | 12031M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 3.2733 | -- | 3.0997 | 3.45543 | 4 |
| FQ3 2029 (Sep 2029) | 3.375 | -- | 3.19601 | 3.56279 | 4 |
| FQ2 2029 (Jun 2029) | 3.3379 | -- | 3.16088 | 3.52362 | 4 |
| FQ1 2029 (Mar 2029) | 3.6996 | -- | 3.50339 | 3.90545 | 4 |
| FQ4 2028 (Dec 2028) | 2.9618 | -- | 2.80472 | 3.1266 | 5 |
| FQ3 2028 (Sep 2028) | 3.074 | -- | 2.91097 | 3.24504 | 5 |
| FQ2 2028 (Jun 2028) | 3.0492 | -- | 2.88749 | 3.21886 | 5 |
| FQ1 2028 (Mar 2028) | 3.4041 | -- | 3.22356 | 3.59351 | 5 |
| FQ4 2027 (Dec 2027) | 2.6835 | -- | 2.59835 | 2.77947 | 4 |
| FQ3 2027 (Sep 2027) | 2.4939 | -- | 2.41476 | 2.58309 | 3 |
| FQ2 2027 (Jun 2027) | 2.5112 | -- | 2.43151 | 2.60101 | 4 |
| FQ1 2027 (Mar 2027) | 2.6123 | -- | 2.52941 | 2.70572 | 3 |
| FQ4 2026 (Oct 2026) | 2.14461 | -- | 2.05564 | 2.21618 | 7 |
| FQ3 2026 (Sep 2026) | 2.03134 | -39.32 | 1.93454 | 2.11044 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 22.35B | -- | 21.44B | 23.31B | 6 |
| FQ3 2029 (Sep 2029) | 22.34B | -- | 21.43B | 23.3B | 4 |
| FQ2 2029 (Jun 2029) | 22.09B | -- | 21.19B | 23.04B | 6 |
| FQ1 2029 (Mar 2029) | 22.97B | -- | 22.04B | 23.96B | 4 |
| FQ4 2028 (Dec 2028) | 20.84B | -- | 19.99B | 21.73B | 5 |
| FQ3 2028 (Sep 2028) | 20.86B | -- | 20.01B | 21.75B | 3 |
| FQ2 2028 (Jun 2028) | 20.65B | -- | 19.8B | 21.53B | 5 |
| FQ1 2028 (Mar 2028) | 21.52B | -- | 20.64B | 22.44B | 3 |
| FQ4 2027 (Dec 2027) | 16.71B | -- | 16.31B | 17.17B | 3 |
| FQ3 2027 (Sep 2027) | 16.41B | -- | 16.01B | 16.86B | 3 |
| FQ2 2027 (Jun 2027) | 16.12B | -- | 15.72B | 16.56B | 3 |
| FQ1 2027 (Mar 2027) | 15.82B | -- | 15.44B | 16.26B | 3 |
| FQ4 2026 (Oct 2026) | 16.35B | -- | 15.82B | 16.77B | 5 |
| FQ3 2026 (Sep 2026) | 16.15B | -93.09 | 15.56B | 16.64B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.83 | 2.83 | 100% | |
| FQ2 2025 (Jun 2025) | 2.13 | 2.13 | 100% | |
| FQ1 2025 (Mar 2025) | 2.62 | 2.62 | 100% | |
| FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 100% | |
| FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 100% | |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 100% | |
| FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 100% | |
| FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $31.19B | $31189M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $29.35B | $29350M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $29.13B | $29134M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $16.11B | $16108M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $15.3B | $15304M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $15.02B | $15019M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $26.27B | $26270M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $12.03B | $12031M | 100% |